Laird Superfood, Inc. (LSF)
NYSEAMERICAN: LSF · Real-Time Price · USD
3.365
-0.100 (-2.89%)
May 28, 2026, 12:23 PM EDT - Market open

Laird Superfood Earnings Call Transcripts

Fiscal Year 2026

  • Q1 2026 saw 20% sales growth, driven by wholesale and Amazon, and the acquisitions of Navitas and Terrasoul. Gross margin contracted due to mix and inflation, but full-year guidance projects $138–$148M in sales and improving EBITDA as synergies are realized.

  • EGM 2026

    Stockholders approved the issuance of preferred stock for the Navitas Acquisition and related executive compensation, following board recommendations. The acquisition and investment are expected to expand scale and product offerings, with final voting results to be reported soon.

Fiscal Year 2025

  • Record 2025 net sales rose 15% to $49.9M, driven by wholesale growth and product innovation. Acquisition of Navitas Organics and $50M Nexus Capital investment position the business for high single-digit sales growth and margin expansion in 2026.

  • M&A Announcement

    A $38.5M cash acquisition of Navitas Organics, funded by Nexus Capital, will create a leading platform in functional nutrition. The deal brings immediate scale, strong synergies, and positions the combined entity for further M&A and innovation in the superfoods market.

  • Q3 2025 saw 10% net sales growth, led by a 39% increase in Wholesale, while e-commerce declined. Gross margin contracted to 36.5% due to inflation and mix, but adjusted EBITDA was positive. New product launches and favorable tariff changes support a 15% full-year sales growth outlook.

  • Q2 2025 net sales rose 20% year-over-year to $12M, led by 47% wholesale growth and strong e-commerce. Gross margin held at 39.9% despite inflation and tariffs, with positive adjusted EBITDA. Full-year guidance for 20%-25% sales growth and break-even EBITDA reaffirmed.

  • Q1 2025 saw 18% net sales growth and a 1.9-point gross margin improvement, with wholesale up 35% and e-commerce up 6% year-over-year. Net loss narrowed to $0.2M, adjusted EBITDA turned positive, and full-year guidance for 20–25% sales growth and upper-30s gross margin was reaffirmed.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Powered by